Citation Tools
PDFClinical/translational cancer immunotherapy
Original research
BND-22, a first-in-class humanized ILT2-blocking antibody, promotes antitumor immunity and tumor regression
Download to a citation manager
Download the citation for this article by clicking on one of the following citation managers:
- Cite this article as:
- BND-22, a first-in-class humanized ILT2-blocking antibody, promotes antitumor immunity and tumor regression